NIN and idiopathic pulmonary fibrosis: This may align with outcomes in treatment of human IPF, where anti-inflammatory approaches are ineffective, but nonetheless, NIN slows disease progression47, apparently by limiting fibrotic encroachment upon the alveolar spaces.